AdvaMedDx® Media Message Points on the VALID Act
AdvaMedDx® has prepared a high-level FAQ document that addresses key questions you may receive about the bill.
Diagnostics
Learn more about our Diagnostics work.
AdvaMed®: VALID Act an “Important Step Toward the Long-Overdue Modernization” of Law Governing Diagnostic Tests
AdvaMed® President and CEO Scott Whitaker and AdvaMedDx® Executive Director Susan Van Meter issued the following statements upon re-introduction today in the House and Senate of the Verifying Accurate, Leading-edge…
Join AdvaMed®DX
AdvaMedDx® members represent the world’s leading diagnostics manufacturers alongside the next generation of companies developing innovative diagnostic tests and technologies in the U.S. and abroad.
AdvaMed®DX Members
AdvaMedDx® members are medical technology firms that manufacture an in vitro diagnostic device or engage in research and development of such diagnostics.
AdvaMedDx®
AdvaMedDx® promotes innovation and expanded access to quality testing.
AdvaMed® Statement on Biden Administration Plan to Expand K-8 Testing
AdvaMed® released a response to the Biden administration’s announcement today of its plan to expand COVID-19 testing in our nation’s K-8 schools.
AdvaMed® Statement on Administration’s Expanded Investment in COVID Testing
WASHINGTON, D.C. – The Advanced Medical Technology Association® (AdvaMed®)—the world’s largest trade association for medical technology and diagnostics companies in the world—released the following statement from President and CEO Scott Whitaker on…
AdvaMed® Re-Launches Web-Based Platform to Assist Government with Potential Supply Shortfalls
AdvaMed® unveiled a newly repurposed platform to help device manufacturers locate and partner with thousands of component part manufacturers and sellers, should they need them during the COVID pandemic.
AdvaMed® Announces 200 Million Molecular COVID-19 Tests Shipped Nationwide
WASHINGTON, D.C. –New data from AdvaMed®’s COVID-19 Diagnostic Supply Registry reveals that total U.S. shipments of COVID-19 molecular diagnostic tests have reached 200 million. A breakdown of the data shows that…
Weekly AdvaMed® COVID-19 Testing Registry Update: Over 190 Million Molecular Tests Shipped Nationwide
WASHINGTON, D.C. – New data from AdvaMed®’s COVID-19 Diagnostic Supply Registry reveals that total U.S. shipments of COVID-19 molecular diagnostic tests have reached over 190 million. A breakdown of the data shows…